09 июля 2002 00:00 |
Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy
Background. Plasma brain natriuretic peptide (BNP), a cardiac hormone secreted mainly by the cardiac ventricles, has been shown to increase in proportion to the degree of cardiac overload. However, whether plasma BNP may serve as a marker for the efficacy of pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension remains unknown.
Methods. Plasma BNP level was measured in 34 patients with chronic thromboembolic pulmonary hypertension before and 1 month after pulmonary thromboendarterectomy. Right heart catheterization was also performed before and 1 month after the operation.
Results. Preoperative plasma BNP level was significantly elevated in patients with chronic thromboembolic pulmonary hypertension compared with control patients (246 ± 40 vs 13 ± 2 pg/mL; p < 0.001; n = 34) and was positively correlated with total pulmonary resistance (r = 0.57; p < 0.001). After pulmonary thromboendarterectomy, plasma BNP level in survivors markedly decreased (220 ± 31 to 54 ± 9 pg/mL; p < 0.001; n = 32) in association with a reduction of total pulmonary resistance (15.6 ± 1.0 to 4.5 ± 0.3 Wood units; p < 0.001). The change in plasma BNP level was closely correlated with that in total pulmonary resistance (r = 0.63; p < 0.001). Importantly, a sustained elevation of plasma BNP (
50 pg/mL) indicated the presence of residual pulmonary hypertension ( 5 Wood units) after operation (sensitivity = 73%; specificity = 81%).
50 pg/mL) indicated the presence of residual pulmonary hypertension ( 5 Wood units) after operation (sensitivity = 73%; specificity = 81%).
Conclusions. Plasma BNP level was strongly associated with the severity of pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension and thereby may serve as a noninvasive marker for the efficacy of pulmonary thromboendarterectomy.
Смотри также
15 июля 2002 | 00:07
Современное лечение язвенной болезни, ассоциированной с Helicobacter pylori.
По данным регистрации заболеваемости в России каждый десятый взрослый житель страдает тем или иным заболеванием органов пищеварения. В некоторых регионах заболеваемость существенно превосходит
09 июля 2002 | 00:07
Surgical considerations for pulmonary actinomycosis
Background. Diagnosis and treatment of pulmonary actinomycosis is difficult without surgical intervention.
Methods. Thirteen patients (10 men, 3 women; mean age, 62 years) underwent pulmonary
09 июля 2002 | 00:07
Surgical treatment of pulmonary hydatid cysts: is capitonnage necessary?
Background. Hydatid disease of the lung caused by Echinococcus granulosus is frequently encountered in Mediterranean countries. The ideal surgical method for treating this disease is still unknown.
09 июля 2002 | 00:07
Sputum retention after lung operation: prospective, randomized trial shows superiority of prophylactic minitracheostomy in high-risk patients
Background. Sputum retention after lung operation is a potentially life-threatening condition. The minitracheostomy (Minitrach II, SIMS Portex, Hythe, Kent, UK) is a 4-mm percutaneous cricothyroidotomy
09 июля 2002 | 00:07
Thymectomy by partial sternotomy for the treatment of myasthenia gravis
Background. Myasthenia gravis is an autoimmune disease characterized by weakness and fatigue of voluntary muscles. Surgical treatment of choice for myasthenia gravis has been thymectomy. However,
